ClinicalTrials.gg
RecruitingNCT06962605Updated Jan 26, 2026

Effects of Intermittent Running on Metabolic Health

An interventional study of Moderate-intensity continuous running (MICE: 60% V̇O2max) and 5-minute interval running (5MIN) in Metabolic Regulation and Energy Expenditure, sponsored by National Taiwan Normal University. Recruiting at 1 site in Taiwan. Open to male participants aged 20 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-01-26.

Sponsored by National Taiwan Normal University · Not applicable, Interventional, and Basic science

How we know

From the registry’s dates

  • Primary completion was expected by Apr 2026, 6 months ago, but the record still lists the study as recruiting.
  • Started Jun 2025; still recruiting 1 year 5 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
16
Allocation
Randomized
Ages
20 Years to 45 Years
Sex
Male
01

Study summary

The purpose of this study is to investigate the suitability of intermittent exercise of long and short intervals at lower intensities than HIIE on energy expenditure during and post-exercise compared to MICE, as well as determine whether similar or greater effects can be achieved for glycemic control in recreationally active adults.

Read the detailed description

The same procedure will be repeated for all trials: Participants will be asked to perform 3 trials in a randomized-crossover design [moderate-intensity continuous running (MICE: 60% V̇O2max), 5-minute interval running (5MIN; 50% and 70% V̇O2max), 2-minute interval running (2MIN; 50% and 70% V̇O2max)]. All trials will be separated by at least 4 days wash-out and less than 14 days between trials to ensure complete rest.

Sensors for measuring muscle oxygen (10 cm proximal to the mid-patella, and 2 cm lateral) will be placed on the rectus femoris muscle and 15 min resting metabolic rate was measured. After baseline measurements, participants warm-up for 3 minutes with fixed walking intensity (i.e., 5 km/h) followed by 40 minutes running. Immediately after the running, participants return to a seated position for 30 minutes post-exercise measurements (EPOC).

During the EPOC and resting metabolic rate (RMR) measurement participants will sit in a comfortable position and need to limit fidgeting, thus allowed only to watch TV or videos on their phone. Participants will be wheeled to the bathroom if needed.

02

Conditions studied

  • Metabolic Regulation
  • Energy Expenditure

Keywords

  • Intermittent running
  • Energy expenditure
03

In context

Lead sponsor

National Taiwan Normal University is the lead sponsor of 64 studies on the registry; 15 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 45 Years
Sexes eligible
Male
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Healthy recreationally active men
  • between 18.5-27 kg/m2
  • Aged between 20 to 45 years
  • Regular exercise (3 times per week and longer than 3 months) with cardio exercise longer than 30 minutes at least once a week
  • Weight stable for more than 3 months (no change in weight +/- 3%)
  • Non-shift workers and sleep at least 6.5-9 hours for the past 3 months
  • Non-smoker

Exclusion criteria

Exclusion Criteria:

  • having any cardiovascular, metabolic or pulmonary disease (angina pectoris or uncontrolled arrhythmias)
  • suffering from infectious contagious diseases,
  • using medications that could affect metabolic responses (including anti-inflammatory medications)
  • smoking
  • heavy alcohol intake (more than 4 drinks on any day or more than 14 drinks a week).
  • undergoing special diets (e.g., intermittent fasting and/or ketogenic diets)
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
16 participants (estimated)

Study arms

  • Experimental
    Moderate-intensity continuous running (MICE: 60% V̇O2max)

    Exercise

    Behavioral: Moderate-intensity continuous running (MICE: 60% V̇O2max)

  • Experimental
    5-minute interval running (5MIN)

    Exercise

    Behavioral: 5-minute interval running (5MIN)

  • Experimental
    2-minute interval running (2MIN)

    Exercise

    Behavioral: 2-minute interval running (2MIN)

Interventions

  • BehavioralModerate-intensity continuous running (MICE: 60% V̇O2max)

    Participants run continuously for 40 minutes at moderate intensity (60-65% V̇O2max)

  • Behavioral5-minute interval running (5MIN)

    Participants run for 40 minutes at average moderate intensity with 5-minutes slow and fast cycles where speed is increased and decreased by 20%.

  • Behavioral2-minute interval running (2MIN)

    Participants run for 40 minutes at average moderate intensity with 2-minutes slow and fast cycles where speed is increased and decreased by 20%.

06

What researchers measure

Primary outcomes

  1. Total energy expenditure

    Changes in total energy expenditure during 40-minutes running and 30 minutes of EPOC

    Time frame: 70 minutes

  2. Substrate utilisation

    Changes in substrate utilisation during 40-minutes running and 30 minutes of EPOC

    Time frame: 70 minutes

Secondary outcomes

  1. Muscle oxygen saturation

    Changes in muscle oxygen during 40 minutes running and 30 minutes EPOC

    Time frame: 70 minutes

  2. Subjective appetite sensation

    Changes in subjective feeling of appetite using 0-100 mm scale (e.g., hunger and satisfaction) during trials

    Time frame: 70 minutes

07

Study locations

1 of 1 sites recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Jun 2025 (actual). Primary completion is estimated for Apr 2026, 10 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 22, 2025
First posted
May 8, 2025
StartActual
Jun 21, 2025
Primary completionEst.
Apr 30, 2026
CompletionEst.
Apr 30, 2026
Last update
Jan 26, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 26, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06962605
Lead sponsor
National Taiwan Normal University
Responsible party
Yung-Chih Chen (Principal Investigator, National Taiwan Normal University) — Principal investigator
First posted
May 8, 2025
Start date
Jun 21, 2025
Primary completion
Apr 30, 2026 (estimated)
Completion
Apr 30, 2026 (estimated)
Last update
Jan 26, 2026

Study contacts

Yung-Chih Chen, PhD
Contact
yc.chen@ntnu.edu.tw
+886277496979

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion